Pfizer Acquires King and Expands Pain Management Portfolio
By Editorial Team
Pharma Deals Review: Vol 2010 Issue 9 (Table of Contents)
Published: 30 Nov-2010
DOI: 10.3833/pdr.v2010.i9.1402 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Pfizer Inc and King Pharmaceuticals Inc have signed an acquisition and merger agreement worth USD 3.6 B with King’s shares being valued at a 40 % premium. King’s pain management portfolio, Meridian auto- injector, and animal health care businesses would complement Pfizer’s existing business lines.
Copyright: © IQVIA 2018
RSS